Incidence and clinical relevance of ASXL2 mutations in adult AML with t(8;21)(q22;q22): A study of the German-Austrian AML Study Group (AMLSG)

被引：0
|
作者：
Jahn, N. [1 ]
Bullinger, L. [1 ]
Weber, D. [1 ]
Corbacioglu, A. [1 ]
Gaidzik, V [1 ]
Agrawal, M. [1 ]
Schlenk, R. [1 ]
Thal, F. [2 ]
Heuser, M. [2 ]
Krauter, J. [3 ]
Goehring, G. [4 ]
Kuendgen, A. [5 ]
Fiedler, W. [6 ]
Luebbert, M. [7 ]
Ganser, A. [2 ]
Doehner, H. [1 ]
Doehner, K. [8 ]
Paschka, P. [1 ]
机构：
[1] Univ Ulm Klinikum, Innere Med Klin 3, Ulm, Germany
[2] Hannover Med Sch, Klin Hamatol Hamostaseol Onkol & Stammzelltranspl, D-30623 Hannover, Germany
[3] Klinikum Braunschweig, Med Klin 3, Braunschweig, Germany
[4] Hannover Med Sch, Inst Humangenet, D-30623 Hannover, Germany
[5] Univ Klinikum, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany
[6] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Hamburg, Germany
[7] Univ Freiburg Klinikum, Klin Innere Med 1, Freiburg, Germany
[8] Univ Ulm Klinikum, Klin Innere Med 3, Ulm, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V538
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [1] Incidence and Prognostic Relevance of ASXL2 Mutations in Adult CBF-AML with t(8;21)(q22; q22): A Study of the German-Austrian AML Study Group (AMLSG)
    Jahn, Nikolaus
    Agrawal, Mridul
    Bullinger, Lars
    Weber, Daniela
    Corbacioglu, Andrea
    Gaidzik, Verena I.
    Thol, Felicitas
    Heuser, Michael
    Krauter, Juergen
    Goehring, Gudrun
    Kuendgen, Andrea
    Fiedler, Walter
    Wattad, Mohammad Amen
    Held, Gerhard
    Kraemer, Doris
    Horst, Heinz A.
    Luebbert, Michael
    Ganser, Arnold
    Schlenk, Richard F.
    Dohner, Hartmut
    Dohner, Konstanze
    Paschka, Peter
    BLOOD, 2015, 126 (23)
  • [2] Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
    N Jahn
    M Agrawal
    L Bullinger
    D Weber
    A Corbacioglu
    V I Gaidzik
    L Schmalbrock
    F Thol
    M Heuser
    J Krauter
    G Göhring
    A Kündgen
    W Fiedler
    M Wattad
    G Held
    C-H Köhne
    H-A Horst
    M Lübbert
    A Ganser
    R F Schlenk
    H Döhner
    K Döhner
    P Paschka
    Leukemia, 2017, 31 : 1012 - 1015
  • [3] Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
    Jahn, N.
    Agrawal, M.
    Bullinger, L.
    Weber, D.
    Corbacioglu, A.
    Gaidzik, V. I.
    Schmalbrock, L.
    Thol, F.
    Heuser, M.
    Krauter, J.
    Goehring, G.
    Kuendgen, A.
    Fiedler, W.
    Wattad, M.
    Held, G.
    Koehne, C-H
    Horst, H-A
    Luebbert, M.
    Ganser, A.
    Schlenk, R. F.
    Doehner, H.
    Doehner, K.
    Paschka, P.
    LEUKEMIA, 2017, 31 (04) : 1012 - 1015
  • [4] Clinical Relevance of Alternatively Spliced Isoform AML1-ETO9a in Adult Patients with t(8;21)(q22; q22.1) Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Weber, Daniela
    Gaidzik, Verena I.
    Habdank, Marianne
    Jahn, Nikolaus
    Schroeder, Thomas Michael
    Kindler, Thomas
    Wattad, Mohammed Amen
    Lubbert, Michael
    Fiedler, Walter
    Gotze, Katharina S.
    Ringhoffer, Mark
    Schleicher, Jan
    Lange, Elisabeth
    Pfreundschuh, Michael
    Griesshammer, Martin
    Greil, Richard
    Kirchen, Heinz
    Koller, Elisabeth
    Thol, Felicitas
    Krauter, Jurgen
    Schlenk, Richard F.
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Paschka, Peter
    Dohner, Hartmut
    Dohner, Konstanze
    BLOOD, 2017, 130
  • [5] Minimal Residual Disease Monitoring in Acute Myeloid Leukemia (AML) with Translocation t(8;21)(q22;q22): Results of the AML Study Group (AMLSG)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Paschka, Peter
    Weber, Daniela
    Gaidzik, Verena I.
    Jahn, Nikolaus
    Kuendgen, Andrea
    Kindler, Thomas
    Wattad, Mohammad Amen
    Luebbert, Michael
    Fiedler, Walter
    Goetze, Katharina
    Ringhoffer, Mark
    Schleicher, Jan
    Lange, Elisabeth
    Held, Gerhard
    Griesshammer, Martin
    Greil, Richard
    Kirchen, Heinz
    Koller, Elisabeth
    Thol, Felicitas
    Krauter, JRgen
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Schlenk, Richard F.
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2016, 128 (22)
  • [6] Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)
    Bacher, Ulrike
    Schnittger, Susanne
    Kern, Wolfgang
    Trenn, Guido
    Weisser, Martin
    Haferlach, Torsten
    Schoch, Claudia
    CANCER GENETICS AND CYTOGENETICS, 2006, 168 (02) : 172 - 174
  • [7] Molecular Characterization of AML with ins(21;8)(q22;q22q22) Reveals Similarity to t(8;21) AML
    Ruecker, Frank G.
    Bullinger, Lars
    Gribov, Alexander
    Sill, Martin
    Schlenk, Richard F.
    Lichter, Peter
    Doehner, Hartmut
    Doehner, Konstanze
    GENES CHROMOSOMES & CANCER, 2011, 50 (01): : 51 - 58
  • [8] Quantitative reverse transcriptase-polymerase chain reaction in AML with t(8;21)(q22;q22)
    Haferlach, T
    LEUKEMIA RESEARCH, 2001, 25 (01) : 55 - 56
  • [9] Good outcome in children with AML and t(8;21) (q22;q22), even associated with granulocytic sarcoma (chloroma).
    Felice, M
    Alfaro, E
    Zubizarreta, P
    Gallego, M
    Cygler, A
    Sackmann-Muriel, F
    BLOOD, 1998, 92 (10) : 200B - 200B
  • [10] B-Cell Expression and B-Cell Gene Rearrangements in AML with t(8;21)(q22;q22)
    Johnson, R. C.
    Ma, L.
    Arber, D. A.
    George, T. I.
    LABORATORY INVESTIGATION, 2012, 92 : 345A - 345A
12345